ArticleCancers2022

Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells.

Kajal Rajput et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.